InspireMD, Inc. (NSPR) Stock

Healthcare · Medical Devices · Member of Other US Stocks

InspireMD, Inc. (NSPR) closed at USD 0.47 on 2026-10-14, a change of -79 % over the past year, with a market capitalization of USD 22.33M.

InspireMD, Inc. recent closing prices

DateClose (USD)
2026-10-140.47
2026-10-130.50
2026-10-120.49
2026-10-090.52
2026-10-080.48
2026-10-070.51
2026-10-060.53

The most recent trading day is not shown. For full charts and indicators use the analysis page.

InspireMD, Inc. key figures

Previous close
USD 0.47 (2026-10-14)
1-year change
-79 %
Market cap
USD 22.33M
Enterprise value
USD -5.06M
P/E ratio (trailing)
-0.81
P/E ratio (forward)
-0.99
EPS (trailing)
-0.59
EPS (forward)
-0.48
PEG ratio
n/a
Price to book
0.71
Revenue growth
-0.4 %
Earnings growth
n/a
Dividend per share (trailing)
0.00
Short ratio
0.39
Employees
127
Analyst consensus (third-party)
none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About InspireMD, Inc.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for InspireMD, Inc. and compare it with other stocks.

Analyze NSPRAll Other US Stocks stocks

Stock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell InspireMD, Inc. shares.